Lung Cancer Research Foundation (LCRF) | 2024 - 5 Calls
Event details
| Date | 04.03.2024 |
| Category | Call for proposal |
CALL 1. Team Science Award (TSA) on Advancing Therapies Towards Curing Oncogene-Driven Lung Cancers
Aim: Work supported through this mechanism should address important mechanistic questions and developmental therapeutics across the care continuum and have the immediate potential to increase survivorship. Given the specific interest in the development of novel therapies that could benefit this group of patients in the relatively near-term, a clinical trial must either be initially incorporated into the project or be an immediate result of the outcome of the research. It is expected that a program of correlative, translational research will be proposed that will enhance the understanding of these oncogenic-driven lung cancers.
Duration: 48 months
Funding: $2,500,000
Eligibility: International teams are encouraged and there are no citizenship requirements. Eligible teams must be comprised of independent faculty-level researchers providing complementary interdisciplinary expertise. The proposal must have a program of 2-3 projects. These projects must be closely integrated and should consist of clinical, basic and/or translational work. For full details, eligibility criteria, and application instructions, please refer to the request for proposals.
More information about the program is available here.
CALL 2. Minority Career Development Award in Lung Cancer
Aim: As minority applicants must overcome systemic and structural barriers due to race, ethnicity, country of origin, socioeconomic status, and/or language, many leave academia which further exacerbates the lack of diversity in Science, Technology, Engineering and Mathematics (STEM) and medical fields. To provide protected time and mentoring to these trainees, LCRF funds the Minority Career Development Award (CDA) for Lung Cancer. Applications can over a wide range of topics.
Duration: 24 months
Funding: $150,000
Eligibility: Minority postdoctoral/clinical fellows and assistant professors within 10 years of completing their MD and/or PhD degrees. For complete details, eligibility criteria, and application instructions, please refer to the request for proposals.
More information about the program is available here.
CALL 3 : Leading Edge Research Grant Program
Aim: The LCRF Leading Edge Research Grant Program aims to fund innovative projects across the full spectrum of basic, translational, clinical, epidemiological, health services, early detection, disparities, and social determinants of health research. Applications can cover a wide range of topics.
Duration: 24 months
Funding: $150,000
Eligibility: There are no citizenship requirements. Candidates should be post-doctoral researchers, clinical fellows, or early- and mid-career investigators with less than 10 years’ experience since their initial faculty appointment.
More information about the program is available here.
CALL 4 : Research Grant on Early Detection and Pre-Neoplasia in Lung Cancer
Aim: Given the significance and need for early detection of lung cancer and advancements in molecular screening, LCRF continues to offer a funding mechanism to support research projects that facilitate or advance the understanding and characterization of pre-neoplasia or approaches for early detection of lung cancer. Work supported through this mechanism addresses important questions in non-small cell and small cell lung cancer. This funding mechanism is focused on identifying, characterizing, and developing approaches and techniques that will allow early detection and/or risk reduction of lung cancer and gaining insight into pre-neoplastic processes in the lungs. The goal is to detect lung cancer at the earliest stages and subsequently increase survival and survivorship.
Duration: 24 months
Funding: $150,000
Eligibility: There are no citizenship requirements. Candidates should be post-doctoral researchers, clinical fellows, or early- and mid-career investigators with less than 10 years’ experience since their initial faculty appointment.
More information about the program is available here.
CALL 5 : Research Grant on Understanding Resistance in Lung Cancer
Aim: This grant mechanism focuses on understanding the development, prevention, and therapy of resistance by supporting research projects that are identifying, characterizing, treating, or preventing resistance to therapies in lung tumor cells, tissues, mouse models, and/or patients. Work supported through this mechanism will address important mechanistic questions and developmental therapeutics across histological subtypes of lung cancer (including lung adenocarcinoma, squamous cell carcinoma and small cell lung cancer) and across the care continuum including newly designed targeted therapies and immunotherapies. These studies will enhance the momentum of improving lung cancer outcomes and have the potential to increase survivorship.
Duration: 24 months
Funding: $150,000
Eligibility: There are no citizenship requirements. Candidates should be post-doctoral researchers, clinical fellows, or investigators with less than 10 years’ experience since their initial faculty appointment.
More information about the program is available here
How to Apply:
Applications should be submitted through the online platform ProposalCentral.
All applications will be evaluated using a two-stage review process that includes review of letters of intent and select full proposals. Only applicants whose LOI is reviewed favorably will be invited to submit a full proposal. A ‘Letter of Support’ will be required at full proposal stage, please reach out to the ReO for assistance with this.
Application Deadline: 04 March 2024 for all Programs
Further information
Aim: Work supported through this mechanism should address important mechanistic questions and developmental therapeutics across the care continuum and have the immediate potential to increase survivorship. Given the specific interest in the development of novel therapies that could benefit this group of patients in the relatively near-term, a clinical trial must either be initially incorporated into the project or be an immediate result of the outcome of the research. It is expected that a program of correlative, translational research will be proposed that will enhance the understanding of these oncogenic-driven lung cancers.
Duration: 48 months
Funding: $2,500,000
Eligibility: International teams are encouraged and there are no citizenship requirements. Eligible teams must be comprised of independent faculty-level researchers providing complementary interdisciplinary expertise. The proposal must have a program of 2-3 projects. These projects must be closely integrated and should consist of clinical, basic and/or translational work. For full details, eligibility criteria, and application instructions, please refer to the request for proposals.
More information about the program is available here.
CALL 2. Minority Career Development Award in Lung Cancer
Aim: As minority applicants must overcome systemic and structural barriers due to race, ethnicity, country of origin, socioeconomic status, and/or language, many leave academia which further exacerbates the lack of diversity in Science, Technology, Engineering and Mathematics (STEM) and medical fields. To provide protected time and mentoring to these trainees, LCRF funds the Minority Career Development Award (CDA) for Lung Cancer. Applications can over a wide range of topics.
Duration: 24 months
Funding: $150,000
Eligibility: Minority postdoctoral/clinical fellows and assistant professors within 10 years of completing their MD and/or PhD degrees. For complete details, eligibility criteria, and application instructions, please refer to the request for proposals.
More information about the program is available here.
CALL 3 : Leading Edge Research Grant Program
Aim: The LCRF Leading Edge Research Grant Program aims to fund innovative projects across the full spectrum of basic, translational, clinical, epidemiological, health services, early detection, disparities, and social determinants of health research. Applications can cover a wide range of topics.
Duration: 24 months
Funding: $150,000
Eligibility: There are no citizenship requirements. Candidates should be post-doctoral researchers, clinical fellows, or early- and mid-career investigators with less than 10 years’ experience since their initial faculty appointment.
More information about the program is available here.
CALL 4 : Research Grant on Early Detection and Pre-Neoplasia in Lung Cancer
Aim: Given the significance and need for early detection of lung cancer and advancements in molecular screening, LCRF continues to offer a funding mechanism to support research projects that facilitate or advance the understanding and characterization of pre-neoplasia or approaches for early detection of lung cancer. Work supported through this mechanism addresses important questions in non-small cell and small cell lung cancer. This funding mechanism is focused on identifying, characterizing, and developing approaches and techniques that will allow early detection and/or risk reduction of lung cancer and gaining insight into pre-neoplastic processes in the lungs. The goal is to detect lung cancer at the earliest stages and subsequently increase survival and survivorship.
Duration: 24 months
Funding: $150,000
Eligibility: There are no citizenship requirements. Candidates should be post-doctoral researchers, clinical fellows, or early- and mid-career investigators with less than 10 years’ experience since their initial faculty appointment.
More information about the program is available here.
CALL 5 : Research Grant on Understanding Resistance in Lung Cancer
Aim: This grant mechanism focuses on understanding the development, prevention, and therapy of resistance by supporting research projects that are identifying, characterizing, treating, or preventing resistance to therapies in lung tumor cells, tissues, mouse models, and/or patients. Work supported through this mechanism will address important mechanistic questions and developmental therapeutics across histological subtypes of lung cancer (including lung adenocarcinoma, squamous cell carcinoma and small cell lung cancer) and across the care continuum including newly designed targeted therapies and immunotherapies. These studies will enhance the momentum of improving lung cancer outcomes and have the potential to increase survivorship.
Duration: 24 months
Funding: $150,000
Eligibility: There are no citizenship requirements. Candidates should be post-doctoral researchers, clinical fellows, or investigators with less than 10 years’ experience since their initial faculty appointment.
More information about the program is available here
How to Apply:
Applications should be submitted through the online platform ProposalCentral.
All applications will be evaluated using a two-stage review process that includes review of letters of intent and select full proposals. Only applicants whose LOI is reviewed favorably will be invited to submit a full proposal. A ‘Letter of Support’ will be required at full proposal stage, please reach out to the ReO for assistance with this.
Application Deadline: 04 March 2024 for all Programs
Further information
- Application portal can be found here
Practical information
- General public
- Free